Cargando…
Vaccine Technologies Jockey for Primacy in Pandemic Response
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935662/ https://www.ncbi.nlm.nih.gov/pubmed/33581346 http://dx.doi.org/10.1016/j.ymthe.2021.02.010 |
_version_ | 1783661047223156736 |
---|---|
author | Dolgin, Elie |
author_facet | Dolgin, Elie |
author_sort | Dolgin, Elie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7935662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-79356622022-03-03 Vaccine Technologies Jockey for Primacy in Pandemic Response Dolgin, Elie Mol Ther Perspective American Society of Gene & Cell Therapy 2021-03-03 2021-02-10 /pmc/articles/PMC7935662/ /pubmed/33581346 http://dx.doi.org/10.1016/j.ymthe.2021.02.010 Text en © 2021. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Perspective Dolgin, Elie Vaccine Technologies Jockey for Primacy in Pandemic Response |
title | Vaccine Technologies Jockey for Primacy in Pandemic Response |
title_full | Vaccine Technologies Jockey for Primacy in Pandemic Response |
title_fullStr | Vaccine Technologies Jockey for Primacy in Pandemic Response |
title_full_unstemmed | Vaccine Technologies Jockey for Primacy in Pandemic Response |
title_short | Vaccine Technologies Jockey for Primacy in Pandemic Response |
title_sort | vaccine technologies jockey for primacy in pandemic response |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935662/ https://www.ncbi.nlm.nih.gov/pubmed/33581346 http://dx.doi.org/10.1016/j.ymthe.2021.02.010 |
work_keys_str_mv | AT dolginelie vaccinetechnologiesjockeyforprimacyinpandemicresponse |